![Dirk Thye](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Dirk Thye
Vorstandsvorsitzender bei
QUINCE THERAPEUTICS, INC.
Vermögen: 116 342 $ am 31.07.2026
Profil
Dirk Thye was the founder of Peninsula Pharmaceuticals, Inc. (founded 2001) and served as Senior Vice President-Clinical Development from 2001 to 2005.
Dr. Thye was the founder of Cerexa, Inc. (founded 2005) and served as President.
Dr. Thye was the founder of Inclin, Inc. (founded 2007) and served as Principal from 2007 to 2014.
Dr. Thye is the founder of Pfluent, Inc. (founded 2011).
Dr. Thye was the founder of Geom Therapeutics, Inc. (founded 2016) and served as Executive Chairman from 2016 to 2020.
Dr. Thye is currently Director, Chief Executive & Medical Officer at Quince Therapeutics, Inc. since 2024.
Former positions include President, CEO, CFO, Secretary & Director at Agenovir Corp.
from 2016 to 2018; Chief Executive Officer & Director at Novosteo, Inc. from 2021 to 2022; Director at Kalyra Pharmaceuticals, Inc.; Manager-Business Process at Quality Planning Corp from 2007 to 2008; and Chief Medical Officer at Cidara Therapeutics, Inc. from 2014 to 2016.
Education includes graduate studies at the University of California, Los Angeles and undergraduate studies at the University of California, Berkeley.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 29.07.2026 | 4’974 ( 0.51% ) | 116 342 $ | 31.07.2026 |
Aktive Positionen von Dirk Thye
| Unternehmen | Position | Beginn |
|---|---|---|
| QUINCE THERAPEUTICS, INC. | Vorstandsvorsitzender | 19.05.2022 |
Ehemalige bekannte Positionen von Dirk Thye
| Unternehmen | Position | Ende |
|---|---|---|
Novosteo, Inc.
 Novosteo, Inc. Pharmaceuticals: MajorHealth Technology Develops drug to reduce complications from a broken bone due to a fall | Vorstandsvorsitzender | 01.05.2022 |
Geom Therapeutics, Inc.
 Geom Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Engages in research and development of antibiotic for MDR gram negative infections | Gründer | 01.07.2020 |
Agenovir Corp.
 Agenovir Corp. BiotechnologyHealth Technology Engages in research and development of human therapeutics for the treatment of diseases | Vorstandsvorsitzender | 01.01.2018 |
| CIDARA THERAPEUTICS | Technik-/Wissenschafts-/F&E-Leiter | 02.09.2016 |
Pfluent, Inc. | Gründer | 01.03.2014 |
Ausbildung von Dirk Thye
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
54
Beziehungen ersten Grades
13
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 13 |
|---|---|
Peninsula Pharmaceuticals, Inc.
 Peninsula Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Develops and commercializes antibiotics to treat life-threatening infections | Commercial Services |
Cerexa, Inc.
 Cerexa, Inc. Pharmaceuticals: MajorHealth Technology Develops biopharmaceutical products | Health Technology |
Kalyra Pharmaceuticals, Inc.
 Kalyra Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures small molecule drugs | Health Technology |
University of California, Los Angeles
 University of California, Los Angeles Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Quality Planning Corp
 Quality Planning Corp Insurance Brokers/ServicesFinance Provides analytic methods to insurance companies for auto insurance ratings | Finance |
University of California, Berkeley
 University of California, Berkeley Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Inclin, Inc.
 Inclin, Inc. Miscellaneous Commercial ServicesCommercial Services Operates contract research organization and provides biometrics, clinical operations, strategic consulting, medical writing, quality assurance, drug safety and medical monitoring services | Commercial Services |
Cidara Therapeutics, Inc.
 Cidara Therapeutics, Inc. Pharmaceuticals: OtherHealth Technology Engages in the discovery, development, and commercialization of novel anti-infectives | Health Technology |
Quince Therapeutics, Inc.
 Quince Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops drugs for the treatment of central nervous system disorders and Alzheimer’s diseases | Health Technology |
Agenovir Corp.
Agenovir Corp. BiotechnologyHealth Technology Engages in research and development of human therapeutics for the treatment of diseases | Health Technology |
Pfluent, Inc. | |
Geom Therapeutics, Inc.
Geom Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Engages in research and development of antibiotic for MDR gram negative infections | Commercial Services |
Novosteo, Inc.
Novosteo, Inc. Pharmaceuticals: MajorHealth Technology Develops drug to reduce complications from a broken bone due to a fall | Health Technology |
